Eleni Tseliou
No Rating Available
(Learn About Our Rating System)

Eleni Tseliou, MD, PhD

Languages spoken: English

Clinical Locations

Primary Location

University of Utah Hospital

50 N Medical Dr
Salt Lake City , UT 84132
801-585-5122
Get Directions

University of Utah Hospital

Heart Failure Clinic
50 N Medical Dr
Salt Lake City , UT 84132
801-585-5122
Get Directions

University of Utah Hospital

Heart Transplant Clinic
50 N Medical Dr
Salt Lake City , UT 84132
801-585-5122
Get Directions

Dr. Tseliou is an Assistant Professor of Medicine in the tenure track appointed to the Division of Cardiology at the University of Utah (UU). Dr. Tseliou received her MD and PhD at University of Athens in Greece and completed her post doctoral fellowship at Cedars Sinai Medical Center and her Internal Medicine, Cardiovascular and Advanced Heart Failure and Transplantation training at the UU. Dr. Tseliou is NIH funded and interested in studying metabolism in heart failure and cardiovascular diseases. Dr. Tseliou’s clinical interests also include care of patients with severe congestive heart failure including the use of mechanical circulatory support devices and cardiac transplantation.

Specialties

Board Certification

American Board of Internal Medicine (Sub: Cardiovascular Disease)
American Board of Internal Medicine (Internal Medicine)
National Board of Echocardiography
Educational Commission for Foreign Medical Graduates

Dr. Tseliou is an Assistant Professor of Medicine in the tenure track appointed to the Division of Cardiology at the University of Utah (UU). Dr. Tseliou received her MD and PhD at University of Athens in Greece and completed her post doctoral fellowship at Cedars Sinai Medical Center and her Internal Medicine, Cardiovascular and Advanced Heart Failure and Transplantation training at the UU. Dr. Tseliou is NIH funded and interested in studying metabolism in heart failure and cardiovascular diseases. Dr. Tseliou’s clinical interests also include care of patients with severe congestive heart failure including the use of mechanical circulatory support devices and cardiac transplantation.

Board Certification and Academic Information

Academic Departments Internal Medicine -Assistant Professor
Academic Divisions Cardiovascular Medicine
Board Certification
American Board of Internal Medicine (Sub: Cardiovascular Disease)
American Board of Internal Medicine (Internal Medicine)
National Board of Echocardiography
Educational Commission for Foreign Medical Graduates

Education history

Professional Medical Medicine - University of Athens School of Medicine M.D.
Doctoral Training University of Athens School of Medicine Ph.D.
Postdoctoral Fellowship Cedars-Sinai Medical Center Postdoctoral Research Fellow
Residency Internal Medicine - Alexandra Hospital Resident
Residency Internal Medicine - University of Utah School of Medicine Resident
Fellowship Cardiovascular Diseases - University of Utah Spencer Fox Eccles School of Medicine Fellow
Fellowship Advanced Heart Failure, Transplant Cardiology and Mechanical Circulatory Support - University of Utah Spencer Fox Eccles School of Medicine Fellow

Selected Publications

Journal Article

  1. Madill-Thomsen KS, Hidalgo LG, Mackova M, Campbell P, Demko Z, Felius J, Gong T, Hall S, Kim DH, Kuczaj A, Lowe D, Maliakkal N, Melenovsky V, Olympios M, Patel S, Prewett A, Przybylowski P, Sayer G, Stehlik J, Tseliou E, Uriel N, Halloran P (2026). Defining the relationships among four tests for assessing antibody-mediated rejection in heart transplants in a prospective, observational study. The Journal of heart and lung transplantation, 45(4), 659-670.
  2. Bergmann O, Tseliou E, Sadek H, Drakos S (2026). Left Ventricular Assist Device-Mediated Unloading and Circulatory Support as a Potential Regenerative Strategy in Advanced Heart Failure. Journal of cardiac failure,
  3. Hamouche R, Tatum SM, Dranow E, Maschek JA, Kyriakopoulos CP, Shankar TS, Visker JR, Ling J, Sideris K, Selzman CH, Kfoury AG, Stehlik J, Alharethi R, Fang JC, Hong T, Navankasattusas S, Rondina MT, Holland WL, Summers SA, Drakos SG, Tseliou (2026). The Role of Sphingolipids in Myocardial Recovery Mediated by Mechanical Unloading and Circulatory Support. JACC. Basic to translational science, 11(1), 101435.
  4. Kyriakopoulos CP, Sideris K, Kyriakoulis I, Taleb I, Maneta E, Zhang C, Tseliou E, Carter S, Florido R, Welt FG, Stehlik J, Selzman CH, Fang JC, Goodwin ML, Tonna JE, Hanff TC, Drakos S (2026). Factors associated with native heart survival and intermediate-term outcomes in acute myocardial infarction-related cardiogenic shock. European heart journal open, 6(1), oeag015.
  5. Sideris K, Bunsawat K, Brinker L, Braun E, Iacovelli J, Chen A, Simmons JM, Zhao J, Carter S, Tseliou E, Kyriakopoulos CP, Hanff TC, Florido R, Brann AM, Fang JC, Greene T, Wray DW, Stehlik (2026). The Effect of Vericiguat on Endothelial Function in Patients With Heart Failure With Reduced Ejection Fraction: A Pilot Randomized Study. The American journal of cardiology, 266, 104-111.
  6. Bonios MJ, Miliopoulos D, Tseliou E, Koliopoulou A, Ieromonachos K, Kogerakis N, Gkouziouta A, Kapelios CJ, Adamopoulos S, Miller D, Drakos SG, Chamogeorgakis (2026). Dissociation Between Interstitial Fibrosis and Conventional Right Ventricular Assessment Markers in Advanced Heart Failure. ASAIO journal (American Society for Artificial Internal Organs,
  7. Madill-Thomsen KS, Hidalgo LG, Mackova M, Demko Z, Prewett A, Campbell P, Felius J, Gong T, Hall S, Kim DH, Kuczaj A, Lowe D, Maliakkal N, Melenovsky V, Olympios M, Patel S, Przybylowski P, Sayer G, Tseliou E, Uriel N, Stehlik J, Halloran PF, Trifecta-Heart Study Grou (2026). Comparing DSA-negative and DSA-positive antibody-mediated rejection in heart transplants: Results from the Trifecta-Heart study. The Journal of heart and lung transplantation,
  8. Taleb I, Kyriakopoulos CP, Wever-Pinzon O, Maneta E, Selzman CH, Dranow E, Tseliou E, Kyriakoulis I, Guglin M, Silvestry SC, Cowger JA, Stehlik J, Fang JC, Hanff TC, Sideris K, Nelson M, Tang D, Abdul-Aziz AA, Parker L, Vidic A, McKellar S, Bonios MJ, Kapelios C, Koliopoulou A, Fillipatos G, Birks EJ, Slaughter MS, Milano C, Karra R, Kanwar MK, Shah P, Drakos S (2026). Determining the Individualized Probability of Myocardial Recovery: The Multicenter RecoverHeart Calculator. The Journal of heart and lung transplantation,
  9. Visker JR, Tseliou E, Drosatos K, Wever-Pinzon O, Holland W, Drakos S (2026). International Utah cardiac recovery symposium (U-CARS) 2025:translational and basic science proceedings. Heart failure reviews, 31(1),
  10. Kim PJ, Olympios M, Sideris K, Tseliou E, Tran TY, Carter S, Brann A, Kaur N, Carey SA, Bhorade S, Chen YA, Barnes D, Ahmed E, Xie J, Prewett A, Rabinowitz M, Zimmermann BG, Bloom MS, Demko Z, Adler E, Stehlik (2025). A two-threshold algorithm using donor-derived cell-free DNA fraction and quantity to detect acute rejection after heart transplantation. American journal of transplantation, 25(9), 1895-1905.
  11. Scott M, Kyriakopoulos CP, Sheffield E, Krauspe E, Sideris K, Taleb I, Maneta E, Tseliou E, Selko S, Hamouche R, Aadland J, Carter SJ, Jones TL, Ou Z, Presson AP, Selzman CH, Tonna JE, Hanff TC, Drakos S (2025). Application of the Updated Cardiogenic Shock Working Group SCAI Classification for Cardiogenic Shock: A Single-Centre Analysis. The Canadian journal of cardiology, 41(10), 2053-2063.
  12. Xie Y, Tucciarone L, Farah EN, Chang L, Yang Q, Shankar TS, Elison W, Tran S, Djulamsah J, Lie A, Loe T, Holman AR, Corban S, Buchanan J, Mamde S, Zhou H, Elgamal RM, Tseliou E, Huang V, Wang Z, Chiu J, Melton R, Griffin E, Zhang Q, Lucero J, Navankasattusas S, Li D, Seng C, Destici E, Selzman CH, D'Antonio-Chronowska A, Wang T, Wang A, Drakos SG, Gaulton KJ, Ren B, Chi N (2025). Single cell multiomics and 3D genome architecture reveal novel pathways of human heart failure.
  13. Bansal N, Maneta E, Zelnick L, Kyriakopoulos CP, Beddhu S, Hartsell S, Stempien-Otero A, Welt F, Tseliou E, Hanff T, Nelson M, Sideris K, Kyriakoulis I, Goldstein J, Mendenhall T, Deol A, Alharethi R, Selzman C, Drakos (2025). Association of Kidney Function With Myocardial Recovery and Adverse Events Following Left Ventricular Assist Device Circulatory Support. Journal of the American Heart Association, 14(24), e043498.
  14. Brinker L, Sideris K, Wei G, Singh R, Nevers MR, Hartsell SE, Sarwal A, Kyriakopoulos CP, Tseliou E, Benes J, Melenovsky V, Drakos SG, Hanff TC, Carter S, Fang JC, Cho M, Beddhu S, Stehlik (2025). Diabetes Therapy With SGLT2i After Heart Transplant: A Multi-Institutional Analysis. JACC. Heart failure, 13(8), 102520.
  15. Kyriakopoulos CP, Sideris K, Taleb I, Maneta E, Tseliou E, Aadland J, Baird AS, Bonios MJ, Nelson M, Dranow E, Goodwin ML, Hanff TC, Carter S, Selzman CH, Stehlik J, Wever-Pinzon O, Ramakrishna S, Tumarkin E, Drakos S (2025). Left Atrial Reverse Remodeling in Patients Supported With Durable Left Ventricular Assist Devices and Clinical Implications. Circulation. Heart failure, 18(7), e012807.
  16. Kyriakopoulos CP, Taleb I, Sideris K, Maneta E, Hamouche R, Tseliou E, Krauspe E, Selko S, Carter S, Jones TL, Zhang C, Presson AP, Dranow E, Geer L, Stehlik J, Selzman CH, Goodwin ML, Tonna JE, Hanff TC, Drakos S (2025). Informing Management of Patients Developing Cardiogenic Shock at a Spoke and Being Transferred to a Hub. Journal of the American Heart Association, 14(4), e035464.
  17. Smoliak O, Rice C, Rudder D, Tseliou E, LaMarre A, LeCouteur A, Gaete J, Davies A, Henshaw (2025). Emotion regulation as affective neoliberal governmentality. Family process, 64(1), e13064.
  18. Visker JR, Tseliou E, Kyriakopoulos CP, Hamouche R, Yin M, Ling J, Shankar TS, Kwan E, Cedeno-Rosaria L, Velasco-Silva JN, Sideris K, Kwak H, Hillas Y, Yannias E, Maneta E, Srinivasan H, Padilla L, Polishchuck G, Navankasattusas S, Tandar A, Ducker GS, Rutter J, Hong T, Shaw RM, Lui C, Welt FG, Drakos S (2025). Peroxisome proliferator-activated receptor gamma ( PPARG )-mediated myocardial salvage in acute myocardial infarction managed with left ventricular unloading and coronary reperfusion. bioRxiv,
  19. Visker JR, Cluntun AA, Velasco-Silva JN, Eberhardt DR, Cedeño-Rosario L, Shankar TS, Hamouche R, Ling J, Kwak H, Hillas JY, Aist I, Tseliou E, Navankasattusas S, Chaudhuri D, Ducker GS, Drakos SG, Rutter (2024). Enhancing mitochondrial pyruvate metabolism ameliorates ischemic reperfusion injury in the heart. JCI insight, 9(17),
  20. Kyriakopoulos CP, Taleb I, Tseliou E, Sideris K, Hamouche R, Maneta E, Nelson M, Krauspe E, Selko S, Visker JR, Dranow E, Goodwin ML, Alharethi R, Wever-Pinzon O, Fang JC, Stehlik J, Selzman CH, Hanff TC, Drakos S (2024). Impact of Diabetes and Glycemia on Cardiac Improvement and Adverse Events Following Mechanical Circulatory Support. Journal of the American Heart Association, 13(14), e032936.
  21. Taleb I, Giannouchos TV, Kyriakopoulos CP, Clawson A, Davis ES, Sideris K, Tseliou E, Shah KS, Tonna JE, Dranow E, Jones TL, Carter SJ, Fang JC, Stehlik J, Ohsfeldt RL, Selzman CH, Hanff TC, Drakos S (2024). Cost-Effectiveness of a Shock Team Approach in Refractory Cardiogenic Shock. Circulation. Heart failure, 17(11), e011709.
  22. Yin MY, Maneta E, Kyriakopoulos CP, Michaels AT, Genovese LD, Indaram MB, Wever-Pinzon O, Singh R, Tseliou E, Taleb I, Nemeh HW, Alharethi R, Tang DG, Goldstein J, Hanff TC, Selzman CH, Cowger J, Kanwar M, Shah P, Drakos S (2024). Cardiac Reverse Remodeling Mediated by HeartMate 3 Left Ventricular Assist Device: Comparison to Older Generation Devices. ASAIO journal (American Society for Artificial Internal Organs, 70(12), 1060-1066.
  23. Kyriakopoulos CP, Sideris K, Taleb I, Maneta E, Hamouche R, Tseliou E, Zhang C, Presson AP, Dranow E, Shah KS, Jones TL, Fang JC, Stehlik J, Selzman CH, Goodwin ML, Tonna JE, Hanff TC, Drakos S (2024). Clinical Characteristics and Outcomes of Patients Suffering Acute Decompensated Heart Failure Complicated by Cardiogenic Shock. Circulation. Heart failure, 17(9), e011358.
  24. Visker JR, Cluntun AA, Velasco-Silva JN, Eberhardt DR, Cedeño-Rosario L, Shankar TS, Hamouche R, Ling J, Kwak H, Hillas JY, Aist I, Tseliou E, Navankasattusas S, Chaudhuri D, Ducker GS, Drakos SG, Rutter (2024). Enhancing mitochondrial pyruvate metabolism ameliorates ischemic reperfusion injury in the heart. JCI insight, 9(21),
  25. Visker JR, Brintz BJ, Kyriakopoulos CP, Hillas Y, Taleb I, Badolia R, Shankar TS, Amrute JM, Ling J, Hamouche R, Tseliou E, Navankasattusas S, Wever-Pinzon O, Ducker GS, Holland WL, Summers SA, Koenig SC, Hanff TC, Lavine KJ, Murali S, Bailey S, Alharethi R, Selzman CH, Shah P, Slaughter MS, Kanwar MK, Drakos S (2024). Integrating molecular and clinical variables to predict myocardial recovery. bioRxiv,
  26. Visker JR, Cluntun AA, Velasco-Silva JN, Eberhardt DR, Shankar TS, Hamouche R, Ling J, Kwak H, Hillas Y, Aist I, Tseliou E, Navankasattusas S, Chaudhuri D, Ducker GS, Drakos SG, Rutter (2024). Enhancing mitochondrial pyruvate metabolism ameliorates myocardial ischemic reperfusion injury. bioRxiv,
  27. Drakos SG, Badolia R, Makaju A, Kyriakopoulos CP, Wever-Pinzon O, Tracy CM, Bakhtina A, Bia R, Parnell T, Taleb I, Ramadurai DKA, Navankasattusas S, Dranow E, Hanff TC, Tseliou E, Shankar TS, Visker J, Hamouche R, Stauder EL, Caine WT, Alharethi R, Selzman CH, Franklin S (2023). Distinct Transcriptomic and Proteomic Profile Specifies Patients Who Have Heart Failure With Potential of Myocardial Recovery on Mechanical Unloading and Circulatory Support. Circulation, 147(5), 409-424.
  28. Khan MS, Kyriakopoulos CP, Taleb I, Dranow E, Scott M, Ranjan R, Yin M, Tseliou E, Alharethi R, Caine W, Shaw RM, Selzman CH, Drakos SG, Dosdall D (2022). Baseline QRS duration associates with cardiac recovery in patients with continuous-flow left ventricular assist device implantation. American heart journal plus, 22, 100211.
  29. Middleton RC, Rogers RG, De Couto G, Tseliou E, Luther K, Holewinski R, Soetkamp D, Van Eyk JE, Antes TJ, Marbán E (2018). Newt cells secrete extracellular vesicles with therapeutic bioactivity in mammalian cardiomyocytes. J Extracell Vesicles, 7(1), 1456888.
  30. Gallet R, Dawkins J, Valle J, Simsolo E, de Couto G, Middleton R, Tseliou E, Luthringer D, Kreke M, Smith RR, Marbán L, Ghaleh B, Marbán E (2017). Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction. Eur Heart J, 38(3), 201-211.
  31. Kanazawa H, Tseliou E, Dawkins JF, De Couto G, Gallet R, Malliaras K, Yee K, Kreke M, Valle I, Smith RR, Middleton RC, Ho CS, Dharmakumar R, Li D, Makkar RR, Fukuda K, Marbán L, Marbán E (2016). Durable Benefits of Cellular Postconditioning: Long-Term Effects of Allogeneic Cardiosphere-Derived Cells Infused After Reperfusion in Pigs with Acute Myocardial Infarction. J Am Heart Assoc, 5(2).
  32. Tseliou E, Kanazawa H, Dawkins J, Gallet R, Kreke M, Smith R, Middleton R, Valle J, Marbán L, Kar S, Makkar R, Marbán E (2016). Widespread Myocardial Delivery of Heart-Derived Stem Cells by Nonocclusive Triple-Vessel Intracoronary Infusion in Porcine Ischemic Cardiomyopathy: Superior Attenuation of Adverse Remodeling Documented by Magnetic Resonance Imaging and Histology. PLoS One, 11(1), e0144523.
  33. Reich H, Tseliou E, de Couto G, Angert D, Valle J, Kubota Y, Luthringer D, Mirocha J, Sun B, Smith RR, Marbán L, Marbán E (2016). Repeated transplantation of allogeneic cardiosphere-derived cells boosts therapeutic benefits without immune sensitization in a rat model of myocardial infarction. J Heart Lung Transplant, 35(11), 1348-1357.
  34. Gallet R, de Couto G, Simsolo E, Valle J, Sun B, Liu W, Tseliou E, Zile MR, Marbán E (2016). Cardiosphere-derived cells reverse heart failure with preserved ejection fraction (HFpEF) in rats by decreasing fibrosis and inflammation. JACC Basic Transl Sci, 1(1-2), 14-28.
  35. Diakos NA, Pozios I, Katsaros L, Vakrou S, Sventzouri S, Michelinakis N, Tseliou E, Bonios M, Malliaras K, Papalois A, Anastasiou-Nana M, Terrovitis JV (2015). Afterload-induced left ventricular diastolic dysfunction during myocardial ischaemia and reperfusion. Exp Physiol, 100(3), 288-301.
  36. Aminzadeh MA, Tseliou E, Sun B, Cheng K, Malliaras K, Makkar RR, Marbán E (2015). Therapeutic efficacy of cardiosphere-derived cells in a transgenic mouse model of non-ischaemic dilated cardiomyopathy. Eur Heart J, 36(12), 751-62.
  37. de Couto G, Liu W, Tseliou E, Sun B, Makkar N, Kanazawa H, Arditi M, Marbán E (2015). Macrophages mediate cardioprotective cellular postconditioning in acute myocardial infarction. J Clin Invest, 125(8), 3147-62.
  38. Gallet R, Tseliou E, Dawkins J, Middleton R, Valle J, Angert D, Reich H, Luthringer D, Kreke M, Smith R, Marbán L, Marbán E (2015). Intracoronary delivery of self-assembling heart-derived microtissues (cardiospheres) for prevention of adverse remodeling in a pig model of convalescent myocardial infarction. Circ Cardiovasc Interv, 8(5).
  39. Tseliou E, Fouad J, Reich H, Slipczuk L, de Couto G, Aminzadeh M, Middleton R, Valle J, Weixin L, Marbán E (2015). Fibroblasts Rendered Antifibrotic, Antiapoptotic, and Angiogenic by Priming With Cardiosphere-Derived Extracellular Membrane Vesicles. J Am Coll Cardiol, 66(6), 599-611.
  40. Kanazawa H, Tseliou E, Malliaras K, Yee K, Dawkins JF, De Couto G, Smith RR, Kreke M, Seinfeld J, Middleton RC, Gallet R, Cheng K, Luthringer D, Valle I, Chowdhury S, Fukuda K, Makkar RR, Marbán L, Marbán (2015). Cellular postconditioning: allogeneic cardiosphere-derived cells reduce infarct size and attenuate microvascular obstruction when administered after reperfusion in pigs with acute myocardial infarction. Circulation. Heart failure, 8(2), 322-32.
  41. Malliaras K, Ibrahim A, Tseliou E, Liu W, Sun B, Middleton RC, Seinfeld J, Wang L, Sharifi BG, Marbán E (2014). Stimulation of endogenous cardioblasts by exogenous cell therapy after myocardial infarction. EMBO Mol Med, 6(6), 760-77.
  42. Yee K, Malliaras K, Kanazawa H, Tseliou E, Cheng K, Luthringer DJ, Ho CS, Takayama K, Minamino N, Dawkins JF, Chowdhury S, Duong DT, Seinfeld J, Middleton RC, Dharmakumar R, Li D, Marbán L, Makkar RR, Marbán E (2014). Allogeneic cardiospheres delivered via percutaneous transendocardial injection increase viable myocardium, decrease scar size, and attenuate cardiac dilatation in porcine ischemic cardiomyopathy. PLoS One, 9(12), e113805.
  43. Samartzis L, Dimopoulos S, Manetos C, Agapitou V, Tasoulis A, Tseliou E, Pozios I, Kaldara E, Terrovitis J, Nanas S (2014). Neuroticism personality trait is associated with Quality of Life in patients with Chronic Heart Failure. World J Cardiol, 6(10), 1113-21.
  44. Tseliou E, Reich H, de Couto G, Terrovitis J, Sun B, Liu W, Marbán E (2014). Cardiospheres reverse adverse remodeling in chronic rat myocardial infarction: roles of soluble endoglin and Tgf-ß signaling. Basic Res Cardiol, 109(6), 443.
  45. Tseliou E, de Couto G, Terrovitis J, Sun B, Weixin L, Marbán L, Marbán E (2014). Angiogenesis, cardiomyocyte proliferation and anti-fibrotic effects underlie structural preservation post-infarction by intramyocardially-injected cardiospheres. PLoS One, 9(2), e88590.
  46. Nguyen C, Fan Z, Xie Y, Dawkins J, Tseliou E, Bi X, Sharif B, Dharmakumar R, Marbán E, Li D (2014). In vivo contrast free chronic myocardial infarction characterization using diffusion-weighted cardiovascular magnetic resonance. J Cardiovasc Magn Reson, 16(1), 68.
  47. Tseliou E, Terrovitis JV, Kaldara EE, Ntalianis AS, Repasos E, Katsaros L, Margari ZJ, Matsouka C, Toumanidis S, Nanas SN, Nanas JN (2014). Red blood cell distribution width is a significant prognostic marker in advanced heart failure, independent of hemoglobin levels. Hellenic J Cardiol, 55(6), 457-61.
  48. Malliaras K, Zhang Y, Seinfeld J, Galang G, Tseliou E, Cheng K, Sun B, Aminzadeh M, Marbán E (2013). Cardiomyocyte proliferation and progenitor cell recruitment underlie therapeutic regeneration after myocardial infarction in the adult mouse heart. EMBO Mol Med, 5(2), 191-209.
  49. Tseliou E, Pollan S, Malliaras K, Terrovitis J, Sun B, Galang G, Marbán L, Luthringer D, Marbán E (2013). Allogeneic cardiospheres safely boost cardiac function and attenuate adverse remodeling after myocardial infarction in immunologically mismatched rat strains. J Am Coll Cardiol, 61(10), 1108-19.
  50. Dimopoulos S, Tzanis G, Manetos C, Tasoulis A, Mpouchla A, Tseliou E, Vasileiadis I, Diakos N, Terrovitis J, Nanas S (2013). Peripheral muscle microcirculatory alterations in patients with pulmonary arterial hypertension: a pilot study. Respir Care, 58(12), 2134-41.
  51. Malliaras K, Smith RR, Kanazawa H, Yee K, Seinfeld J, Tseliou E, Dawkins JF, Kreke M, Cheng K, Luthringer D, Ho CS, Blusztajn A, Valle I, Chowdhury S, Makkar RR, Dharmakumar R, Li D, Marbán L, Marbán E (2013). Validation of contrast-enhanced magnetic resonance imaging to monitor regenerative efficacy after cell therapy in a porcine model of convalescent myocardial infarction. Circulation, 128(25), 2764-75.
  52. Cheng K, Malliaras K, Shen D, Tseliou E, Ionta V, Smith J, Galang G, Sun B, Houde C, Marbán E (2012). Intramyocardial injection of platelet gel promotes endogenous repair and augments cardiac function in rats with myocardial infarction. J Am Coll Cardiol, 59(3), 256-64.
  53. Terrovitis J, Zotos P, Kaldara E, Diakos N, Tseliou E, Vakrou S, Kapelios C, Chalazonitis A, Nanas S, Toumanidis S, Kontoyannis D, Karga E, Nanas J (2012). Bone mass loss in chronic heart failure is associated with secondary hyperparathyroidism and has prognostic significance. Eur J Heart Fail, 14(3), 326-32.
  54. Bouchla A, Karatzanos E, Dimopoulos S, Tasoulis A, Agapitou V, Diakos N, Tseliou E, Terrovitis J, Nanas S (2011). The addition of strength training to aerobic interval training: effects on muscle strength and body composition in CHF patients. J Cardiopulm Rehabil Prev, 31(1), 47-51.
  55. Dimopoulos S, Diakos N, Tseliou E, Tasoulis A, Mpouchla A, Manetos C, Katsaros L, Drakos S, Terrovitis J, Nanas S (2011). Chronotropic incompetence and abnormal heart rate recovery early after left ventricular assist device implantation. Pacing Clin Electrophysiol, 34(12), 1607-14.

Review

  1. Hamouche R, Summers SA, Holland WL, Navankasattusas S, Drakos SG, Tseliou (2025). The role of sphingolipids in heart failure. European heart journal open, 5(3), oeaf035.
  2. Taleb I, Tseliou E, Fang JC, Drakos SG (2022). A Mechanical Bridge to Recovery as a Bridge to Discovery: Learning From Few and Applying to Many. [Review]. Circulation, 145, (8), 562-564.
  3. Tseliou E, Lavine KJ, Wever-Pinzon O, Topkara VK, Meyns B, Adachi I, Zimpfer D, Birks EJ, Burkhoff D, Drakos SG (2022). Biology of myocardial recovery in advanced heart failure with long-term mechanical support. [Review]. J Heart Lung Transplant, 41, (10), 1309-1323.

Commentary

  1. Harrington J, Tseliou E, Shah S, Shah KS (2022). Paying Homage to the Power of Proteomics: Insights Into Obesity and Heart Failure From the HOMAGE Trial. J Card Fail, 28(5), 787-788.
  2. Bonios MJ, Tseliou E, Drakos SG (2021). Commentary: Major lessons from minor people: Beta blockers and cytokinesis in tetralogy of Fallot. J Thorac Cardiovasc Surg, 161(5), 1592-1593.

Case Report

  1. Papachatzakis Y, Tseliou E, Tatouli I, Dialoupi I, Michas F, Papadopoulou E, Kousouris D, Kontogiannis S, Dimopoulos MA (2016). Colon Adenoma Implicating Myasthenia Gravis: A Case Report of a Patient with Postcolectomy Complications. Case Rep Neurol Med, 2016 6297656.

Editorial

  1. Tseliou E, Stehlik (2025). Severe primary graft dysfunction of the transplanted heart-more than a single category?. The Journal of heart and lung transplantation, 44(7), 1063-1065.

Letter

  1. Yin MY, Tandar A, Sharma V, Glotzbach JP, Shah RU, Dranow E, Tseliou E, Fang JC, Drakos SG, Welt FGP (2020). Left Ventricular Hemodynamic Changes During Transcatheter Aortic Valve Replacement Assessed by Real-Time Pressure-Volume Loops. [Letter to the editor]. JACC Cardiovasc Interv, 13(18), 2190-2192.
  2. Koudoumas D, Terrovitis J, Glentis P, Ntalianis A, Tsolakis E, Zannas AS, Tseliou E, Papalois A, Drakos S, Nanas JN (2017). Comparison of two biventricular infarct patterns with respect to the infarct burden required to induce cardiogenic shock: An experimental study. [Letter to the editor]. Hellenic J Cardiol, 58(4), 306-309.
  3. Agapitou V, Dimopoulos S, Mpouchla A, Samartzis L, Tseliou E, Kaldara E, Terrovitis J, Tasoulis A, Karga E, Nanas S (2011). Serum intact parathyroid hormone levels independently predict exercise capacity in stable heart failure patients. [Letter to the editor]. Int J Cardiol, 146(3), 462-4.